Two weeks after recovering from COVID-19, I developed an itchy rash in the skin folds (under breasts, bilateral arms, buttocks, back, abdomen) despite using Aveeno lotion and not taking diphenhydramine (Benadryl); what treatment is recommended?

Post-COVID-19 Intertriginous Rash: Treatment Recommendations

Immediately discontinue all cosmetic products in the affected skin folds, begin treatment with a mid-to-high potency topical corticosteroid (such as triamcinolone 0.1% or clobetasol 0.05%), start oral antihistamines for symptomatic relief of pruritus, and maintain aggressive moisturization with fragrance-free, preservative-free products applied to damp skin after every washing. 1

Clinical Context

Your presentation is consistent with either:

• Contact dermatitis (irritant or allergic) affecting intertriginous zones (skin folds under breasts, arms, buttocks, back, abdomen) 1
• Post-COVID-19 urticarial or inflammatory dermatitis, which can present 2-3 weeks after acute infection 2, 3, 4

The distribution in skin folds suggests a contact or irritant component, potentially triggered or exacerbated by immune dysregulation following COVID-19 infection 5.

Immediate Management Steps

1. Topical Corticosteroid Therapy

• Apply a mid-to-high potency topical corticosteroid (triamcinolone 0.1% or clobetasol 0.05%) to all affected areas twice daily 1
• Use steroids only on affected skin and limit duration because prolonged use damages the skin barrier, especially in thin, occluded intertriginous areas 1
• For extensive involvement (>20% body surface area) or severe vesiculation, stronger potency agents may be warranted 1

2. Oral Antihistamine Therapy

• Start oral diphenhydramine (Benadryl) 25-50 mg every 6 hours as needed for pruritus 6, 2, 3, 5, 4
• Antihistamines are the primary recommended therapy for post-COVID-19 urticarial and pruritic rashes 2, 5
• Alternative non-sedating antihistamines (cetirizine, loratadine, fexofenadine) can be used if daytime sedation is problematic 3

3. Aggressive Moisturization Protocol

• Apply fragrance-free, preservative-free, dye-free moisturizer immediately after every washing while skin is still damp to trap moisture 1
• Use tube-packaged products rather than jars to reduce contamination risk 1
• Apply two fingertip units per affected area for adequate coverage 1
• For severe cases, employ "soak-and-smear" technique nightly for up to 2 weeks: soak affected areas in lukewarm water for 20 minutes, apply moisturizer to damp skin, then cover with loose cotton clothing 1

4. Complete Product Avoidance

• Discontinue ALL cosmetic products in affected areas: antiperspirants, deodorants, body washes, lotions, powders, shaving creams 1
• Avoid common allergens: fragrances, preservatives (formaldehyde, benzalkonium chloride, benzisothiazolinone), topical antibiotics (neomycin, bacitracin), lanolin, rubber chemicals 1
• Avoid irritants: bleach, harsh soaps, antibacterial agents, disinfectant wipes, adhesive bandages containing bacitracin 1

5. Modified Hygiene Practices

• Cleanse with lukewarm water and gentle, fragrance-free synthetic detergent (avoid hot/cold water, harsh soaps) 1
• Pat dry gently—no rubbing—and apply moisturizer immediately 1
• Limit washing to necessary hygiene only; avoid excessive cleansing 1

Expected Timeline & Follow-Up

• Most post-COVID-19 cutaneous manifestations are self-limiting and resolve within 7-14 days with appropriate treatment 2, 5, 4
• If no improvement after 4-6 weeks of allergen avoidance, moisturization, and topical steroids, escalate to stronger topical corticosteroids, consider phototherapy or systemic immunosuppressive therapy, and refer to dermatology 1

When to Seek Urgent Evaluation

• Signs of secondary infection: increased pain, warmth, purulent drainage, fever 1
• Severe or rapidly spreading dermatitis despite appropriate therapy 1
• Systemic symptoms: respiratory distress, chest pain, severe headache (consider COVID-19 reinfection or complications) 7, 8

Diagnostic Considerations

Patch Testing Indications

Consider dermatology referral for patch testing if: 1

• Dermatitis does not improve after 4-6 weeks of avoidance and treatment
• Severe or spreading disease despite appropriate management
• Occupational exposure suspected
• Atypical distribution or pattern
• History suggests product-related worsening

Patch testing is the gold-standard diagnostic tool for allergic contact dermatitis and should include an extended allergen series plus the patient's actual products 1

Common Pitfalls to Avoid

• Do not continue using Aveeno or any product that appears to worsen the condition, even if previously tolerated 1
• Do not pick at scales or inflamed skin—this perpetuates inflammation 1
• Do not use superglue to seal fissures—it contains potential allergens 1
• Do not apply adhesive bandages containing bacitracin or benzalkonium chloride to minor cuts 1

Special Considerations for Post-COVID-19 Patients

• Cutaneous manifestations can be the initial or delayed presentation of COVID-19, occurring weeks after acute infection 2, 3, 4
• Urticarial and maculopapular rashes are among the most common post-COVID-19 dermatologic findings 5, 4
• Treatment with combination oral steroids and high-dose antihistamines has been effective for severe post-COVID-19 urticarial reactions 3
• Patients with pre-existing atopic conditions have increased risk of developing contact dermatitis and should be especially vigilant 1